Cancer Biomarkers
A cancer biomarker mentions to a material or process that is indicative
of the attendance of cancer in the body. A biomarker may be a molecule secreted
by a tumor or a precise reaction of the body to the presence of cancer.
Biological fragment convert in blood, other body fluids, or tissues that
is a sign of a normal or abnormal process, or of a state or disease. A
biomarker may be used to see how well the body proceeds to a action for a disease
or condition. One of the most well-known cancer biomarkers is Prostate-specific
antigen, or PSA, and higher levels of PSA in men tend to signal for prostate
cancer. Actually, cancer biomarkers are more than just a signal of the disease,
and have many roles in the competition against cancer.
Cancer biomarkers identified so far
- Oral Cancer
- Breast Cancer
- Liver Cancer
- Pancreas Cancer
- Colon Cancer
- Ovarian and Cervical Cancer
- Prostate Cancer
- Brain Cancer
- Thyroid Cancer
- Lung Cancer
- Kidney Cancer
- Bladder Cancer
Biomarkers are
limited to measurement of proteins in the blood or urine.
Biomarkers refers to a substance or process that indicates the presence
of cancer in the body. There are different biomarkers used
for the prognosis, diagnosis and epidemiology like epigenetic,
Genetic, glycomics, proteomic, and imaging biomarkers. A number
of gene and protein based biomarkers have already been used
at some point in patient care; including:
PSA (Prostate Specific Antigen) (Prostate Cancer),
AFP (Liver Cancer),
BRCA1 / BRCA2 (Breast/Ovarian Cancer),
CA-125 (Ovarian Cancer), BCR-ABL (Chronic Myeloid
Leukemia),
- Protein
biomarkers
- Fluorescent
biomarkers
- Cancer
Risk evaluation
- Cancer
epidemiology biomarkers
- Prognosis
and treatment
- Biomarkers
in Cancer Research
- Cancer
Rheumatology
- Diagnostic
biomarker
- Prognostic
biomarkers
- Stratification
(predictive) biomarker
Comments
Post a Comment